Spring sale! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ads free!Spring sale! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ads free today!Spring sale! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

Celltrion
Biotech
Moderna
Topics

Advertisement

Celltrion

Share

Top Latest Popular

🐣 SPRING SALE! Go ads free in 2026, with NewsNow Essentials for just £2.99 a month!

🐣 SPRING SALE! Stay informed ads free in 2026, with NewsNow Essentials for just £2.99 a month! Upgrade today!

Celltrion’s Zymfentra sees 185% surge in US prescriptions The Korea Herald 3d

The Korea Herald 3d

Celltrion obtains Japanese approval for Steqeyma IV formulation Korea Biomedical Review 09:09 Tue, 21 Apr

Korea Biomedical Review 09:09 Tue, 21 Apr

Japan Inflammatory Bowel Disease

Celltrion highlights new CT-P13 SC data at DDW 2026, reinforcing IBD treatment potential Korea Biomedical Review 4d

Korea Biomedical Review 4d

Inflammatory Bowel Disease

Advertisement

Advertisement

Celltrion files Herceptin biosimilar SC formulation with EMA Korea Biomedical Review 09:03 Thu, 30 Apr

Korea Biomedical Review 09:03 Thu, 30 Apr

European Medicines Agency

Celltrion’s profit doubles as biosimilar demand drives record revenue The Korea Times 5d

The Korea Times 5d

Pharma Biotechnology

Celltrion launches Avtozma in Japan, entering tocilizumab market as first mover Korea Biomedical Review 05:14 Tue, 28 Apr

Korea Biomedical Review 05:14 Tue, 28 Apr

Japan Tocilizumab

Advertisement

Advertisement

Latest

Friday

Celltrion’s Zymfentra sees 185% surge in US prescriptions The Korea Herald 03:36 Fri, 08 May

Thursday

Celltrion highlights new CT-P13 SC data at DDW 2026, reinforcing IBD treatment potential Korea Biomedical Review 05:34 Thu, 07 May

Wednesday

Celltrion posts record first-quarter results Miami Herald 16:04 Wed, 06 May

Celltrion Q1 Net Income Rises RTT News 05:32 Wed, 06 May

Celltrion’s profit doubles as biosimilar demand drives record revenue The Korea Times 04:08 Wed, 06 May

Celltrion’s Q1 operating profit more than doubles on biosimilar growth Korea Biomedical Review 03:35 Wed, 06 May

Celltrion posts record Q1 earnings on strong biosimilar sales The Korea Herald 03:26 Wed, 06 May

Celltrion Q1 net income up over 3-fold on high-margin products Yonhap News Agency 01:47 Wed, 06 May

In the last month

Celltrion files Herceptin biosimilar SC formulation with EMA Korea Biomedical Review 09:03 Thu, 30 Apr

Celltrion enters Japanese market for arthritis treatments with new biosimilar The Korea Times 07:27 Tue, 28 Apr

Advertisement

Advertisement

Advertisement

About our Celltrion news

Latest news on Celltrion, a biopharmaceutical company headquartered in Incheon, South Korea.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Industry Sectors Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna